StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30152% above fair value
$56.95+1.58 (+2.85%)

Close on Nov 18, 2026Market cap $3.40BP/E –Yield –

Axogen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Axogen's operating cash flow for the twelve months ending Sep 30, 2026 was $28.36M, up 335.7% year over year. For fiscal 2025 it was $812.00K, down 82.1% from the year before. The highest annual figure on record is $4.54M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$812.00K-82.1%
FY2024Dec 31, 2024$4.54M–
FY2023Dec 31, 2023-$5.72M–
FY2022Dec 31, 2022-$16.07M–
FY2021Dec 31, 2021-$13.41M–
FY2020Dec 31, 2020-$9.63M–
FY2019Dec 31, 2019-$19.87M–
FY2018Dec 31, 2018-$17.86M–
FY2017Dec 31, 2017-$9.24M–
FY2016Dec 31, 2016-$11.24M–
FY2015Dec 31, 2015-$13.05M–
FY2014Dec 31, 2014-$10.45M–
FY2013Dec 31, 2013-$10.44M–
FY2012Dec 31, 2012-$8.66M–
FY2011Dec 31, 2011-$7.08M–
FY2010Dec 31, 2010-$3.94M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$16.54M+413.1%
Q2 FY2026Jun 30, 2026$7.22M-6.6%
Q1 FY2026Mar 31, 2026$1.57M–
Q4 FY2025Dec 31, 2025$3.04M-65.2%
Q3 FY2025Sep 30, 2025$3.22M-17.4%
Q2 FY2025Jun 30, 2025$7.73M+85.6%
Q1 FY2025Mar 31, 2025-$13.18M–
Q4 FY2024Dec 31, 2024$8.74M–
Q3 FY2024Sep 30, 2024$3.90M+139.9%
Q2 FY2024Jun 30, 2024$4.17M+1326.4%
Q1 FY2024Mar 31, 2024-$12.27M–
Q4 FY2023Dec 31, 2023-$211.00K-115.5%
Q3 FY2023Sep 30, 2023$1.63M–
Q2 FY2023Jun 30, 2023$292.00K–
Q1 FY2023Mar 31, 2023-$7.42M–
Q4 FY2022Dec 31, 2022$1.36M–
Q3 FY2022Sep 30, 2022-$689.00K–
Q2 FY2022Jun 30, 2022-$5.69M–
Q1 FY2022Mar 31, 2022-$11.05M–
Q4 FY2021Dec 31, 2021-$1.51M-153.4%
Q3 FY2021Sep 30, 2021-$376.00K-114.4%
Q2 FY2021Jun 30, 2021-$695.00K–
Q1 FY2021Mar 31, 2021-$10.82M–
Q4 FY2020Dec 31, 2020$2.84M–
Q3 FY2020Sep 30, 2020$2.62M–
Q2 FY2020Jun 30, 2020-$7.03M–
Q1 FY2020Mar 31, 2020-$8.05M–
Q4 FY2019Dec 31, 2019-$3.33M–
Q3 FY2019Sep 30, 2019-$1.86M–
Q2 FY2019Jun 30, 2019-$5.81M–
Q1 FY2019Mar 31, 2019-$8.87M–
Q4 FY2018Dec 31, 2018-$4.98M–
Q3 FY2018Sep 30, 2018-$2.97M–
Q2 FY2018Jun 30, 2018-$4.08M–
Q1 FY2018Mar 31, 2018-$5.84M–
Q4 FY2017Dec 31, 2017-$1.05M–
Q3 FY2017Sep 30, 2017-$2.16M–
Q2 FY2017Jun 30, 2017-$2.07M–
Q1 FY2017Mar 31, 2017-$3.95M–
Q4 FY2016Dec 31, 2016-$1.46M–

More Axogen figures

See a number that looks wrong?